how to mix semaglutide 5 mg A new study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Link in bio GLOW Peptide Dosage & Protocol

Beyond the obesity data, the Phase 3 study ACHIEVE-1 in people with early type 2 diabetes over 40 weeks documented an HbA1c change of -1.24, -1.47, and -1.48 percentage points at 3, 12, and 36 mg, versus -0.41 percentage points under placebo (Fras et al., NEJM 2025)

Its important to let your patients know as they will often blame the last medicine given on any negative effects

For administration parameters in laboratory work, see our Melanotan II dosing protocol, which sits within the wider library of peptide guides and dosing protocols

The next wave of obesity medicine may include stronger, more complex metabolic therapies

If no drop appears, repeat the flow check or try a new needle